Karista

Beev is a mobility platform based in Paris, France, founded in 2020, that provides electric vehicle solutions for both businesses and households. The company facilitates the decarbonization of mobility by offering a comprehensive service that includes the purchase of electric vehicles and the installation of charging stations in various locations, such as homes and public spaces. Beev's platform emphasizes user convenience through features like online signatures, price transparency, and flexible payment options, enabling customers to save time and money while making the transition to electric mobility.

UpFactor is an independent consultancy based in Paris, France, specializing in site analysis and large-scale detection of aerial land potential. Founded in 2017, the company utilizes a geographic information system that aggregates essential data for assessing building possibilities, including addresses, street widths, building heights, zoning regulations, solar land registers, and protected areas. UpFactor provides building heightening services that enable property owners to increase the number of floors on existing structures. This approach allows businesses to expand their usable space within already developed areas, promoting sustainable development while minimizing land use. The firm combines expertise in architecture, engineering, and law to support real estate and construction sectors effectively.

TISSIUM is a privately owned medical device company based in Paris, France, focused on developing and commercializing innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, bind effectively to tissues, and provide on-demand wound closure in the body’s dynamic environments. TISSIUM's technology is rooted in advanced research and intellectual property from renowned experts at MIT and Brigham & Women’s Hospital. The company aims to address various unmet clinical needs through its proprietary portfolio of fully biosynthetic, biomorphic, and programmable polymers. Founded in 2013, TISSIUM is supported by prominent healthcare investors, emphasizing its commitment to advancing surgical techniques through its groundbreaking solutions.

Admo.tv is the best TV analytics platform that helps TV & radio advertisers to measure and optimise the online impact of their offline investments. Admo.tv optimises, in average, about 30% the R.O.I. of its clients by providing the finest analysis in terms of incremental visits and conversion of their media investments. Admo.tv is a start-up that has offices in Paris and operates in more than 12 different countries worldwide. Admo.tv optimise every day the offline investments of the best advertising agencies (Dentsu Aegis, Havas…) and top-tier brands such as Accor, Allianz, Ford, Meetic, La Redoute, and more.

Acticor Biotech is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the urgent need for effective therapies in the acute phase of ischemic stroke, a condition that affects approximately 15 million people globally each year, leading to significant mortality and disability. Currently, there is a lack of effective treatment options, with existing therapies demonstrating limited efficacy and accessibility. Acticor Biotech seeks to provide innovative solutions to improve outcomes for stroke patients, addressing a critical gap in current medical care.

Acticor Biotech is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the urgent need for effective therapies in the acute phase of ischemic stroke, a condition that affects approximately 15 million people globally each year, leading to significant mortality and disability. Currently, there is a lack of effective treatment options, with existing therapies demonstrating limited efficacy and accessibility. Acticor Biotech seeks to provide innovative solutions to improve outcomes for stroke patients, addressing a critical gap in current medical care.

AppScho, SAS, established in 2014 and headquartered in Paris, France, specializes in mobile application software for higher education. Its application centralizes essential information for students and educational institutions, providing access to schedules, grades, school events, and employment opportunities. The app enhances student engagement by offering features such as course previews, classroom details, and notifications for schedule changes. Additionally, it facilitates communication between institutions and students, allowing educators to monitor student engagement and analyze performance. By streamlining campus content and services, AppScho aims to improve the overall academic experience and support students in managing their studies effectively.

Acticor Biotech is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the urgent need for effective therapies in the acute phase of ischemic stroke, a condition that affects approximately 15 million people globally each year, leading to significant mortality and disability. Currently, there is a lack of effective treatment options, with existing therapies demonstrating limited efficacy and accessibility. Acticor Biotech seeks to provide innovative solutions to improve outcomes for stroke patients, addressing a critical gap in current medical care.

Precogs is a company based in Paris, France, founded in 2011, that specializes in business analytics solutions tailored for EMS-ODM-OEM sectors. The company offers a range of services, including supply risk management, enterprise resource planning (ERP), and procurement monitoring. Its key products feature CogWatch, a predictive tool leveraging big data, and Cog Margin, a platform designed for component pricing. Precogs focuses on providing real-time sourcing of electronic components, ensuring that clients receive competitive pricing for their needs.

Acticor Biotech is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the urgent need for effective therapies in the acute phase of ischemic stroke, a condition that affects approximately 15 million people globally each year, leading to significant mortality and disability. Currently, there is a lack of effective treatment options, with existing therapies demonstrating limited efficacy and accessibility. Acticor Biotech seeks to provide innovative solutions to improve outcomes for stroke patients, addressing a critical gap in current medical care.

Nexdot specializes in the synthesis, production, and application of advanced semiconductor nanocrystals known as Quantum Dots (QDs), with a focus on nanoplatelets—two-dimensional nanosheet Quantum Dots that exhibit enhanced properties. Founded as a spin-off from a leading academic laboratory in Paris, Nexdot leverages over a decade of research in nanomaterials to create proprietary materials with controlled shape and composition. These innovations are poised to transform various industries, including displays, lighting, energy storage, detectors, and bio-imaging. Additionally, Nexdot is developing quantum pearl encapsulation technology to enhance the integration of quantum plates into existing production processes, thereby ensuring compliance with environmental regulations. The company is comprised of a dynamic team of skilled scientists and seasoned executives, dedicated to advancing innovation in the field of nanotechnology.

Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.

Nexdot specializes in the synthesis, production, and application of advanced semiconductor nanocrystals known as Quantum Dots (QDs), with a focus on nanoplatelets—two-dimensional nanosheet Quantum Dots that exhibit enhanced properties. Founded as a spin-off from a leading academic laboratory in Paris, Nexdot leverages over a decade of research in nanomaterials to create proprietary materials with controlled shape and composition. These innovations are poised to transform various industries, including displays, lighting, energy storage, detectors, and bio-imaging. Additionally, Nexdot is developing quantum pearl encapsulation technology to enhance the integration of quantum plates into existing production processes, thereby ensuring compliance with environmental regulations. The company is comprised of a dynamic team of skilled scientists and seasoned executives, dedicated to advancing innovation in the field of nanotechnology.

BnbSitter, established in 2013 and headquartered in Paris, France, specializes in streamlining short-term rental management. Through its online platform, the company offers on-demand concierge services, enabling vacation rental hosts to book essential services like guest check-in/check-out and rental cleaning swiftly and efficiently, ensuring a smooth and welcoming experience for guests.

TISSIUM is a privately owned medical device company based in Paris, France, focused on developing and commercializing innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, bind effectively to tissues, and provide on-demand wound closure in the body’s dynamic environments. TISSIUM's technology is rooted in advanced research and intellectual property from renowned experts at MIT and Brigham & Women’s Hospital. The company aims to address various unmet clinical needs through its proprietary portfolio of fully biosynthetic, biomorphic, and programmable polymers. Founded in 2013, TISSIUM is supported by prominent healthcare investors, emphasizing its commitment to advancing surgical techniques through its groundbreaking solutions.

Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.

Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.

Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.

Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.

Open Ocean SAS is a company that specializes in developing a SaaS-based decision-making platform focused on managing offshore infrastructure and marine operations. Founded in 2011 and headquartered in Paris and Brest, the company offers a range of products and services, including the Metocean Analytics solution, which analyzes atmospheric and oceanic conditions, and a detailed report on the tidal energy market in France. Additionally, Open Ocean provides a spectral wave database for Scotland, facilitating the development of marine renewable energy. Its services encompass site data analysis, resource and energy assessment, environmental data for design calculations, and research and development for offshore energy projects. Open Ocean caters to farm developers, operators, and public agencies within the renewable marine energy sector, leveraging a highly qualified team of oceanographers skilled in high-resolution modeling and data analysis.

Precogs is a company based in Paris, France, founded in 2011, that specializes in business analytics solutions tailored for EMS-ODM-OEM sectors. The company offers a range of services, including supply risk management, enterprise resource planning (ERP), and procurement monitoring. Its key products feature CogWatch, a predictive tool leveraging big data, and Cog Margin, a platform designed for component pricing. Precogs focuses on providing real-time sourcing of electronic components, ensuring that clients receive competitive pricing for their needs.

TISSIUM is a privately owned medical device company based in Paris, France, focused on developing and commercializing innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, bind effectively to tissues, and provide on-demand wound closure in the body’s dynamic environments. TISSIUM's technology is rooted in advanced research and intellectual property from renowned experts at MIT and Brigham & Women’s Hospital. The company aims to address various unmet clinical needs through its proprietary portfolio of fully biosynthetic, biomorphic, and programmable polymers. Founded in 2013, TISSIUM is supported by prominent healthcare investors, emphasizing its commitment to advancing surgical techniques through its groundbreaking solutions.

Fidzup is a Paris-based company that offers web-oriented tools tailored for brick-and-mortar businesses. Established in 2013, it has developed a distinctive in-store analytics platform that enables retailers to retarget customers with personalized mobile advertisements. By integrating Wi-Fi and GPS technology, Fidzup's local marketing platform tracks the behavior of mobile users both at the point of sale and in surrounding areas. This capability allows retailers to gather valuable data on consumer behavior, analyze it effectively, and deliver targeted advertisements directly to customers’ mobile devices, thereby enhancing local market engagement.

Fidzup is a Paris-based company that offers web-oriented tools tailored for brick-and-mortar businesses. Established in 2013, it has developed a distinctive in-store analytics platform that enables retailers to retarget customers with personalized mobile advertisements. By integrating Wi-Fi and GPS technology, Fidzup's local marketing platform tracks the behavior of mobile users both at the point of sale and in surrounding areas. This capability allows retailers to gather valuable data on consumer behavior, analyze it effectively, and deliver targeted advertisements directly to customers’ mobile devices, thereby enhancing local market engagement.

Up & Net SAS, established in 2005 and headquartered in Paris, France, specializes in e-payment services tailored for e-commerce. The company focuses on developing innovative gift card solutions that are utilized by online merchants. In addition to its core offerings, Up & Net publishes Cadeaux-avenue.com, a gift-giving platform, and Monblogshopping.com, a collection of blogs centered around shopping. The company also creates private e-payment programs and distributes e-gift cards, which can be re-materialized for use in convenience stores. Through these services, Up & Net aims to enhance the shopping experience for consumers and provide valuable tools for online retailers.

Sequans Communications S.A. is a designer and supplier of cellular semiconductor solutions, specializing in 4G and 5G chips and modules tailored for massive, broadband, and critical Internet of Things (IoT) markets. Established in 2003 and headquartered in Paris, France, the company offers a diverse product portfolio that includes its Monarch LTE-M/NB-IoT and Calliope Cat 1 chip platforms for 5G/4G massive IoT applications, known for their low power consumption and integrated functionalities. For broadband and critical IoT applications, Sequans provides the Cassiopeia Cat 4/Cat 6 4G and high-end Taurus 5G chip platforms, which are optimized for various sectors including residential, enterprise, and industrial uses. The company serves a global market with additional offices in the United States, United Kingdom, Israel, Hong Kong, Singapore, Taiwan, South Korea, and China.

Sequans Communications S.A. is a designer and supplier of cellular semiconductor solutions, specializing in 4G and 5G chips and modules tailored for massive, broadband, and critical Internet of Things (IoT) markets. Established in 2003 and headquartered in Paris, France, the company offers a diverse product portfolio that includes its Monarch LTE-M/NB-IoT and Calliope Cat 1 chip platforms for 5G/4G massive IoT applications, known for their low power consumption and integrated functionalities. For broadband and critical IoT applications, Sequans provides the Cassiopeia Cat 4/Cat 6 4G and high-end Taurus 5G chip platforms, which are optimized for various sectors including residential, enterprise, and industrial uses. The company serves a global market with additional offices in the United States, United Kingdom, Israel, Hong Kong, Singapore, Taiwan, South Korea, and China.

Echosens SAS, established in 2001 and headquartered in Paris, France, specializes in developing, manufacturing, and marketing non-invasive diagnostic products and services for hepatology. The company's flagship product, FibroScan, utilizes vibration-controlled transient elastography technology, which is utilized in both clinical practice and research to assess liver health. Additionally, Echosens offers FibroMeter, a blood test that quantifies liver fibrosis, and FibroView, a smart connectivity software that integrates FibroScan data with hospital information systems. Echosens aims to lead the market in non-invasive hepatology diagnostics and is dedicated to enhancing patient quality of life.

Xcalia specializes in intermediation software designed to facilitate the creation of dynamic transactional composite applications. The Xcalia Intermediation Platform integrates legacy systems, mainframe resources, and databases with web services to streamline and orchestrate business processes. This platform employs metadata to describe services and automate transaction execution in real-time, enabling enterprises to adapt swiftly to evolving business needs without incurring the high costs associated with manual integration. Established in 2000 and headquartered in Paris, France, Xcalia serves over 50 companies, enhancing high-volume transactional environments. The company also maintains offices in the United States, the United Kingdom, and Germany.

Sequans Communications S.A. is a designer and supplier of cellular semiconductor solutions, specializing in 4G and 5G chips and modules tailored for massive, broadband, and critical Internet of Things (IoT) markets. Established in 2003 and headquartered in Paris, France, the company offers a diverse product portfolio that includes its Monarch LTE-M/NB-IoT and Calliope Cat 1 chip platforms for 5G/4G massive IoT applications, known for their low power consumption and integrated functionalities. For broadband and critical IoT applications, Sequans provides the Cassiopeia Cat 4/Cat 6 4G and high-end Taurus 5G chip platforms, which are optimized for various sectors including residential, enterprise, and industrial uses. The company serves a global market with additional offices in the United States, United Kingdom, Israel, Hong Kong, Singapore, Taiwan, South Korea, and China.

Xcalia specializes in intermediation software designed to facilitate the creation of dynamic transactional composite applications. The Xcalia Intermediation Platform integrates legacy systems, mainframe resources, and databases with web services to streamline and orchestrate business processes. This platform employs metadata to describe services and automate transaction execution in real-time, enabling enterprises to adapt swiftly to evolving business needs without incurring the high costs associated with manual integration. Established in 2000 and headquartered in Paris, France, Xcalia serves over 50 companies, enhancing high-volume transactional environments. The company also maintains offices in the United States, the United Kingdom, and Germany.